Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AVTX

Avalo Therapeutics Inc

Jun 08 • 04:00PM ET

12.74

-0.36 -2.75 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: KYMR NUVL RYTM INCY BMRN VKTX KRYS AXSM MDGL NBIX

| Held by: VTI VXF IWC ITOT TMSL DFAS DFMC TMED BMED TNXT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.82	Insider Own	8.96%	Shs Outstand	52.57M	Perf Week	-19.11%
Market Cap	669.69M	Forward P/E	-	EPS next Y	-3.15	Insider Trans	-6.34%	Shs Float	47.86M	Perf Month	-44.29%
Enterprise Value	589.88M	PEG	-	EPS next Q	-0.62	Inst Own	66.40%	Short Float	13.07%	Perf Quarter	-26.40%
Income	-84.74M	P/S	11161.44	EPS this Y	45.93%	Inst Trans	28.10%	Short Ratio	4.09	Perf Half Y	-29.03%
Sales	0.06M	P/B	4.59	EPS next Y	0.30%	ROA	-71.09%	Short Interest	6.25M	Perf YTD	-29.85%
Book/sh	2.77	P/C	8.15	EPS next 5Y	20.30%	ROE	-88.76%	52W High	24.27 -47.51%	Perf Year	210.73%
Cash/sh	1.56	P/FCF	-	EPS past 3/5Y	82.35% 70.20%	ROIC	-120.51%	52W Low	4.06 213.79%	Perf 3Y	-98.72%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-85.16% -61.19%	Gross Margin	-283.05%	Volatility	8.66% 7.78%	Perf 5Y	-99.87%
Dividend TTM	-	EV/Sales	9831.27	EPS Y/Y TTM	-1121.44%	Oper. Margin	-134164.41%	ATR (14)	1.29	Perf 10Y	-99.81%
Dividend Ex-Date	-	Quick Ratio	7.66	Sales Y/Y TTM	-86.62%	Profit Margin	-143627.12%	RSI (14)	32.08	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	7.66	EPS Q/Q	21.93%	SMA20	-21.66%	Beta	0.86	Target Price	46.18
Payout	-	Debt/Eq	0.03	Sales Q/Q	-	SMA50	-18.58%	Rel Volume	0.68	Prev Close	13.10
Employees	33	LT Debt/Eq	0.03	Earnings	May 13 BMO	SMA200	-17.12%	Avg Volume	1.53M	Price	12.74
IPO	Nov 13, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	4.42% -	Trades		Volume	1,043,947	Change	-2.75%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)